Abstract
While derangements in glucose metabolism in patients with primary hyperparathyroidism are well-defined, this issue is not investigated in patients with normocalcemic primary hyperparathyroidism (NPHPT). The aim of this study was to investigate the presence of insulin resistance in patients with NPHPT. Eighteen patients with NPHPT (two males and 16 females) and 18 healthy volunteers were enrolled into the study. Secondary causes of parathyroid hormone elevations were excluded in all patients. Blood samples were obtained for the measurement of serum calcium, phosphate, alkaline phosphatase (ALP), albumin, creatinine, glucose, and serum lipid levels. Glucose and insulin responses to oral glucose tolerance test (OGTT) were obtained. Homeostasis model assessment (HOMA-IR) was also used as an indice of insulin resistance. Patients and control subjects had similar age, body mass index, and sex distribution. Although within normal limits, serum calcium and ALP levels were higher in patients than in the control subjects. None of the patients and the control subjects had diabetes mellitus, while eight patients and six control subjects had impaired glucose tolerance. Insulin responses to OGTT and HOMA-IR were not significantly different among the patient and control subjects. In addition, both groups have similar serum lipid levels. Patients with NPHPT do not exhibit insulin resistance and glucose intolerance. Since so little is known about this form of disease, subjects should be monitored regularly for the metabolic aspects of the disease as well as the progression of their disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
S.J. Silverberg, J.P. Bilezikian, “Incipient” primary hyperparathyroidism. A “forme fruste” of an old disease. J. Clin. Endocrinol. Metab. 88, 5348–5352 (2003)
L.H. Duntas, N. Stathatos, Cinacalcet as alternative treatment for primary hyperparathyroidism: achievements and prospects. Endocrine 39, 199–204 (2011)
H. Lowe, D.J. McMahon, M.R. Rubin, J.P. Bilezikian, S.J. Silverberg, Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J. Clin. Endocrinol. Metab. 92, 3001–3005 (2007)
M. Procopio, G. Magro, F. Cesario et al., The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed Type 2 diabetes mellitus in primary hyperparathyroidism. Diabetic Med. 19, 958–961 (2002)
E. Hagstrom, E. Lundgren, H. Lithell et al., Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. Clin. Endocrinol. 56, 253–260 (2002)
W.H. Taylor, A.A. Khaleeli, Coincident diabetes mellitus and primary hyperparathyroidism. Diabetes Metab. Res. Rev. 17, 175–180 (2001)
S. Valdemarsson, P. Lindblom, A. Bergenfelz, Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of surgical treatment. J. Int. Med. 244, 241–249 (1998)
S. Ayturk, A. Gursoy, N. Bascil Tutuncu, D.T. Ertugrul, N. Guvener Demirag, Changes in insulin sensitivity and glucose and bone metabolism over time in patients with asymptomatic primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 91, 4260–4263 (2006)
E. Hagstrom, E. Lundgren, J. Rastad, P. Hellman, Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening. Eur. J. Endocrinol. 155, 33–39 (2006)
E. Bonora, G. Targher, M. Alberiche et al., Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 23, 57–63 (2000)
American Diabetes Association: clinical practice recommendations 1997. Diabetes Care 20(Suppl 1), S1–S70 (1997)
N.B. Dimkovic, A.A. Wallele, D.G. Oreopoulos, Renal stone disease, elevated iPTH level and normocalcemia. Int. Urol. Nephrol. 34, 135–141 (2002)
R.E. Burney, K.R. Jones, B. Christy, N.W. Thompson, Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels. Surgery 125, 608–614 (1999)
E. Hagstrom, P. Hellman, E. Lundgren, L. Lind, J. Arnlov, Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community-based cohort. Diabetologia 50, 317–324 (2007)
A.A. Khaleeli, J.N. Johnson, W.H. Taylor, Prevalence of glucose intolerance in primary hyperthyroidism and the benefit of parathyroidectomy. Diabetes Metab. Res. Rev. 23, 43–48 (2007)
G. Sun, S. Vasdev, G.R. Martin, V. Gadag, H. Zhang, Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance and beta cell function in the Newfoundland population. Diabetes 54, 3336–3339 (2005)
T. Yamaguchi, I. Kanazawa, S. Takaoka, T. Sugimoto, Serum calcium is positively correlated with fasting plasma glucose and insulin resistance, independent of parathyroid hormone, in male patients with type 2 diabetes mellitus. Metab. Clin. Exp. 60, 1334–1339 (2011)
F. Tassone, M. Procopio, L. Gianotti, G. Visconti, A. Pia, M. Terzolo, G. Borretta, Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidism. Diabet Med. 26, 968–973 (2009)
J.P. Bilezikian, S.J. Silverberg, Normocalcemic primary hyperparathyroidism. Arq. Bras. Endocrinol. Metab. 54, 106–109 (2010)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cakir, I., Unluhizarci, K., Tanriverdi, F. et al. Investigation of insulin resistance in patients with normocalcemic primary hyperparathyroidism. Endocrine 42, 419–422 (2012). https://doi.org/10.1007/s12020-012-9627-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-012-9627-x